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Carcinoembryonic antigen cell adhesion molecule
like I (CEACAM1) is expressed on activated T cells
and signals through either a long (L) cytoplasmic
tail containing immune receptor tyrosine based
inhibitory motifs, which provide inhibitory function,
or a short (S) cytoplasmic tail with an unknown role.
Previous studies on peripheral T cells show that
CEACAM1-L isoforms predominate with little to no
detectable CEACAM1-S isoforms in mouse and
human. We show here that this was not the case in
tissue resident T cells of intestines and gut associ-
ated lymphoid tissues, which demonstrated predom-
inant expression of CEACAM1-S isoforms relative to
CEACAM1-L isoforms in human and mouse. This
tissue resident predominance of CEACAM1-S ex-
pression was determined by the intestinal environ-
ment where it served a stimulatory function leading
to the regulation of T cell subsets associated with
the generation of secretory IgA immunity, the regula-
tion of mucosal commensalism, and defense of the
barrier against enteropathogens.
INTRODUCTION
Carcinoembryonic antigen cell adhesionmolecule 1 (CEACAM1),
a member of the carcinoembryonic antigen family, is engaged
in intercellular binding interactions that affect signal transduction930 Immunity 37, 930–946, November 16, 2012 ª2012 Elsevier Inc.by a number of cell surface receptors. CEACAM1 is constitu-
tively expressed by a variety of cell types, including those of
endothelial, epithelial, and hematopoietic origin such as B cells,
polymorphonuclear leukocytes, monocytes, and dendritic cells.
In addition, CEACAM1 is expressed at minimal quantities in
circulating natural killer (NK) and T cells but is upregulated in
these cell types following a variety of different forms of activation
(Azuz-Lieberman et al., 2005; Boulton and Gray-Owen, 2002;
Coutelier et al., 1994; Nakajima et al., 2002; Singer et al., 2002).
On the cell surface, CEACAM1 can associate with and modify
the function of numerous signaling receptors that are dictated
by the CEACAM1 isoforms expressed. The individual CEACAM1
isoforms are generated by alternative splicing and consist of
transmembrane proteins that possess a characteristic mem-
brane distal, immunoglobulin V (IgV)-like domain (the N domain),
which functions in homophilic binding but differs with respect
to the number of membrane proximal extracellular IgC2-like
domains and the length of their cytoplasmic tail (Gray-Owen
and Blumberg, 2006). Specifically, the 11 human and 4 mouse
CEACAM1 splice variants encode either a short (S) cytoplasmic
tail about which little is known or a long (L) cytoplasmic tail
containing immune receptor tyrosine-based inhibitory motifs
(ITIM). In the latter case, consistent with the presence of ITIM
motifs in their cytoplasmic tail, the CEACAM1-L isoforms of
mice and humans are linked to inhibition of many different sig-
naling receptors (Chen et al., 2001 and 2008; Kammerer et al.,
1998; Pan and Shively, 2010). In each example, the inhibitory
function of CEACAM1-L isoforms is triggered by the phos-
phorylation of the ITIM tyrosine residues by receptor tyrosine
kinases or Src-related kinases, resulting in recruitment of the
Src homology 2 (SH2) domain-containing protein-tyrosine phos-
phatases (SHP)-1 or -2 (Huber et al., 1999; Nagaishi et al., 2006).
Immunity
Function of CEACAM1-S in Intestinal T CellsThus,CEACAM1-L-mediated recruitment of thesephosphatases
results in the dephosphorylation of critical tyrosines contained
within activating motifs associated with a variety of cell surface
receptors such as the B cell receptor, epidermal growth factor
receptor and T cell receptor (TCR)-CD3 complex (Abou-Rjaily
et al., 2004; Boulton and Gray-Owen, 2002; Chen et al., 2008;
Loboet al., 2009). As such,CEACAM1-L isoformsare functionally
inhibitory and are the major isoforms described in mouse and
human lymphocytes including NK cells, B cells, and T cells.
CEACAM1-L and CEACAM1-S isoforms are expressed at
varying ratios in different cell types with recent evidence showing
that such expression is under the influence of cytokines (e.g.,
interferon-g), transcription factors (e.g., IRF-1), and splicing
regulators (e.g., members of the heterogeneous nuclear ribonu-
cleoprotein family) (Dery et al., 2011; Gencheva et al., 2010).
Although not directly demonstrated, this is presumed to be the
case for T lymphocytes as well. It is known that although mouse
and human T cells predominantly express CEACAM1-L iso-
forms, there is some evidence that CEACAM1-S isoforms can
be expressed. However, this is a controversial issue because
little or no detection has been described depending upon the
study (Donda et al., 2000; Singer et al., 2002). This is not an
inconsequential issue, because in vitro transfection studies in
T cells suggest that CEACAM1 is a ‘‘tunable’’ receptor system
given that CEACAM1-S isoforms may possess costimulatory
function that is capable of ameliorating the inhibitory signals
provided by CEACAM1-L isoforms in the context of TCR-CD3
complex signaling when expressed together (Chen and Shively,
2004a; Chen et al., 2008). However, there is no information avail-
able on CEACAM1 isoform regulation in T cells in vivo and the
physiologic function(s) that this might confer.
To this end, we have focused our attention on the regulation
of CEACAM1 isoform expression and function within intestinal
tissues in order to shed light on the normal physiologic roles of
CEACAM1 in these compartments. We have done so given the
fact that CEACAM1 can function as a microbial receptor and
the gastrointestinal surface is in direct contact with large con-
centrations of commensal and pathogenic microbes (Kuespert
et al., 2006). In addition, CEACAM1 expression is increased on
the cell surface of T cells in human diseases such as Celiac
disease and inflammatory bowel disease (Donda et al., 2000;
Morales et al., 1999). Furthermore, in vivo ligation of CEACAM1
with CEACAM1 homophilic ligands as provided by N-domain-
Fc-fusion proteins or forced expression of CEACAM1-L isoforms
in T cells is able to prevent or block mucosal inflammation asso-
ciated with either hapten-mediated colitis or naive T cell transfer
models of colitis (Iijima et al., 2004; Nagaishi et al., 2006). To-
gether, these studies predict an important physiological role
for CEACAM1 in mucosal tissues of the gastrointestinal tract.
In this study, we have identified a key role for CEACAM1 in
regulating steady-state secretory immunity in the intestines. By
establishing a PCR method for quantifying mouse CEACAM1-S
and CEACAM1-L variants, we found that T cells within the
intestines, relative to peripheral tissues such as the spleen, not
only exhibited increased overall CEACAM1 expression but also
uniquely possessed a relative overabundance of CEACAM1-S
relative to CEACAM1-L isoforms. Moreover, in this environment,
we showed that CEACAM1-S isoforms have special physiolog-
ical functions, which at a cellular level enhanced T cell activationIindependently of CEACAM1-L isoforms and were preferentially
expressed in cells performing common mucosal immune func-
tions. Specifically, we found that CEACAM1-S acts as an
individual signaling unit, which promotes the induction of
CD4+LAP+ regulatory T (Treg) cells, CD4+PD1+CXCR5+ follicular
helper T cells (Tfh cells), and the development of IgA committed
B cells within Peyer’s patches (PP). Consistent with this, T cell-
associated CEACAM1-S isoforms led to enhanced mucosal
IgA secretion, which influenced both the composition of com-
mensal microbiota and host defense against exposure to
pathogens such as Listeria monocytogenes. In the absence of
CEACAM1 expression, these barrier-protective functions were
diminished. Together, these studies provide tissue-specific
evidence for CEACAM1 isoform regulation linked to important
physiological functions within the intestines.
RESULTS
Intestinal T Cells Predominantly Express CEACAM1-S
Isoforms while Extraintestinal T Cells Mainly Express
CEACAM1-L
The expression of CEACAM1 isoforms in hematopoietic cells has
not been systematically examined outside peripheral sites such
as the spleen and blood. We therefore compared CEACAM1
expression on mouse splenic T cells to the quantities expressed
on T cells from intestinal tissues under homeostatic conditions.
Interestingly, the proportion of T cells that stained positive for
CEACAM1 was increased on T cells obtained from colonic
lamina propria (LP) and PP in comparison to that observed on
T cells isolated from either spleen or mesenteric lymph nodes
(MLN) as defined by staining with the CC1 monoclonal antibody
(mAb), a mouse anti-mouse CEACAM1 antibody (Dveksler et al.,
1993) (Figure 1A). These studies showed that T cells within intes-
tinal mucosal tissues displayed substantially greater CEACAM1
amounts on the cell surface under steady-state conditions in
comparison to those within nonmucosal sites.
We next assessed the relative expression of CEACAM1 iso-
forms, and to do so we first established a quantitative assay
for analyzing expression of mouse CEACAM1-L and -S variants
because currently available antibodies are not able to distinguish
between these twogeneral classes of CEACAM1 in a quantitative
fashion. Two pairs of real-time PCR primers were designed
to specifically quantify these in mouse T cells. The specificity
and efficiency of these primers was verified using mouse (m)
CEACAM1-4L (4L) and CEACAM1-4S (4S) plasmids (see Fig-
ure S1A available online). Quantitative PCR (qPCR) analysis of
mouse primary CD3+ T cells isolated from spleen and lymph
nodes (LN) demonstrated that CEACAM1-L isoforms predomi-
nated in resting peripheral T cells with increased expression
upon anti-CD3 stimulation as previously described (Boulton
and Gray-Owen, 2002; Nakajima et al., 2002) (Figure S1B).
In addition, although CEACAM1-S isoforms were detected,
CEACAM1-L isoforms predominated in peripheral T cells such
that the CEACAM1-L:CEACAM1-S (L:S) ratio was 1.95 ± 0.34,
consistent with previous studies (Singer et al., 2002).
Having validated this qPCR assay with splenic T cells, we per-
formed a broad survey of CEACAM1 isoform expression in pri-
mary T cells isolated from several different tissues. It was noted
that, unlike CD3+ T cells isolated from spleen or MLN whereinmmunity 37, 930–946, November 16, 2012 ª2012 Elsevier Inc. 931
Figure 1. Intestinal T Cells Predominantly Express CEACAM1-S Isoforms
(A) Cell surface expression of CEACAM1 (CC1 antibody) on CD3+ T cells from spleen, MLN, PP, or lamina propria (LP) of colon from C57BL/6 mice.
(B) qPCR for transcriptional analysis of CEACAM1-L and -S in CD3+ T cells isolated from spleen,MLN, blood, PP, or segments of small intestine and colon LP from
WT mice.
(C) Cell surface expression of CEACAM1 (5F4 antibody) on CD3+ T cells from human peripheral blood (PBMC) or colon LP.
(D) Semiquantification of the relative transcription of CEACAM1-L andCEACAM1-S in humanCD3+ T cells isolated fromperipheral bloodwith indicated treatment
or from fresh colon LP.
(E) qPCR for quantification of CEACAM1-L and CEACAM1-S transcription in naive CD3+ T cells from WT mice, MLN T cells from WT mice, and CD3+ T cells
isolated from spleen and colon LP of Rag2/ mice adoptively transferred with WT CD4+ naive T cells.
(F) T cells isolated frommouse LP were expanded with ConA and IL-2 in vitro for 2 weeks and the expression of CEACAM1-L and CEACAM1-S were determined
by qPCR.
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Function of CEACAM1-S in Intestinal T CellsCEACAM1 expression was low and CEACAM1-L isoforms
predominated over CEACAM1-S isoforms, CD3+ T cells from
the intestinal LP of the duodenum, jejunum, ileum, colon, and
PP were observed to express an overall increase in CEACAM1
transcript abundance with significantly greater quantities of
CEACAM1-S isoforms relative to CEACAM1-L isoforms. Thus,
an average L:S ratio of <1.0 (PP, 0.53 ± 0.08; small intestine,
0.36 ± 0.11; and colon, 0.19 ± 0.04) was observed, which was
reversed from peripheral T cells (Figure 1B). Accordingly, it
was noted that the quantity and L:S ratio of CEACAM1 expres-
sion varied cephalocaudally along the axis of the gut. Specifi-
cally, the amounts of CEACAM1 and L:S ratio were more similar
to spleen, MLN, and peripheral blood in the proximal intestines.
Furthermore, CEACAM1 expression increased and the L:S ratio
progressively decreased from the distal small intestine (ileum) to
the colon. As a result, LP T cells of the PP and colon contained
the highest amount of CEACAM1 and the lowest L:S ratios rela-
tive to all other compartments examined (Figure 1B). This was
verified by immunoblotting with the CC1mAb, further confirming
that T cells isolated from PP and colonic LP expressed higher932 Immunity 37, 930–946, November 16, 2012 ª2012 Elsevier Inc.CEACAM1 amounts relative to peripheral blood and especially
CEACAM1-S isoforms, which was most notable in the colonic
LP (Figure S1C). These studies both confirmed the increased
expression of CEACAM1 within intestinal T cells and further indi-
cated that CEACAM1-S isoforms were not only expressed by
primary T cells but established that they were, surprisingly, the
major isoform within intestinal T cells.
Given these observations, we also determined whether
CEACAM1-S isoforms predominated in T cells obtained from
the LP of human colon. In a first group of studies, we confirmed
that, in comparison to peripheral T cells, a greater proportion of
T cells from the human colon expressed CEACAM1 on the cell
surface as we had previously observed in mouse (Figure 1C;
Figure S1D). Moreover, using previously published RT-PCR
primers, which amplify a 160 bp fragment from all CEACAM1-S
cDNAs and a 210 bp fragment from all CEACAM1-L cDNAs
from human CEACAM1 (Chen et al., 2008; Singer et al., 2002),
we confirmed that CEACAM1 was barely detectable in resting
peripheral blood T cells (Figure 1D). However, after activation
with either phytohemagglutinin (PHA) or interleukin-2 (IL-2),
Immunity
Function of CEACAM1-S in Intestinal T CellsCEACAM1 was induced and CEACAM1-L isoforms became the
dominant typedetected (Figure1D, left panel). In contrast to these
observations with peripheral blood T cells and similar to the find-
ings obtained with intestinal T cells from mice, CD3+ T cells from
the LP of human colon exhibited readily detectable CEACAM1
at baseline with markedly elevated quantities of CEACAM1-S
relative to CEACAM1-L when compared to that observed in
CD3+ T cells from peripheral blood (Figure 1D, right panel).
Preferential Expression of CEACAM1-S over
CEACAM1-L Isoforms Requires Continuous Exposure
to Mucosa-Associated Factors
Together, these studies demonstrated that intestinal T cells from
both mouse and human uniquely expressed CEACAM1-S iso-
forms in particularly high quantities. In addition, this dominance
of CEACAM1-S expression by intestinal T cells was not simply
due to T cell activation because activation of peripheral blood
T cells did not induce significant quantities of CEACAM1-S (Fig-
ure S1B) nor were significant quantities of CEACAM1-S detect-
able in T cells from the spleen or peripheral blood (Figures 1B
and 1D). Given this, we hypothesized that CEACAM1 expression
and especially that of CEACAM1-S isoforms in T cells was
regulated by signals encountered within the intestinal microenvi-
ronment. We therefore addressed this question by adoptively
transferring spleen-derived, naive CD4+CD62L+ T cells from
wild-type (WT) mice that expressed little detectable CEACAM1
expression by flow cytometry (data not shown) but with low
amounts of predominantly CEACAM1-L transcripts as shown
by qPCR into Rag2/ mice and analyzed CEACAM1 isoform
expression in the adoptively transferred T cells after 2 weeks,
prior to the development of intestinal inflammation (Figure 1E).
These studies showed that, whereas T cells isolated from the
MLN and spleens of the Rag2/ recipients expressed low-
to-moderate amounts of CEACAM1 expression with an L:S ratio
of approximately 1.0, the T cells that homed to the LP of the colon
expressed substantially increased CEACAM1with an L:S ratio of
approximately 0.1–0.2, consistent with a significant dominance
of CEACAM1-S isoforms. Thus, peripheral T cells entering the in-
testines expressed not only increased quantities of CEACAM1
but also a marked dominance of CEACAM1-S isoforms.
We also questioned whether these effects by intestinal milieu
were imprinted and thus irreversible. To do so, we examined
the expression of CEACAM1-S isoforms associated with CD3+
T cells obtained from colonic LP before and after two weeks
of ex vivo culture with concanavalin-A and IL-2. These studies
showed that dominant expression of CEACAM1-S isoforms
was lost under such conditions (Figure 1F) and demonstrated
that the L:S ratio observed within intestinal tissues is deter-
mined by, and requires continuous exposure to, the relevant
mucosal factors. Considering that CEACAM1-S expression pre-
dominated in colon LP T cells from germ-free SwissWebster and
C57BL/6 mice (Figures S1E and S1F), Myd88/ (Figure S1G),
and Nod2/ (Figure S1H) mice, the factors responsible for this
phenotype were neither dependent upon the presence of com-
mensal microbiota nor microbial-induced signaling.
The alternative splicing of CEACAM1depends upon regulatory
cis-acting elementswithin exon 7 and flanking introns (Dery et al.,
2011). Recently, the trans-acting auxiliary splicing factors hetero-
geneous nuclear ribonucleoprotein (hnRNP) L, hnRNP A1, andIhnRNP M variants were shown to associate with exon 7 of
the CEACAM1 messenger RNA (mRNA) and control splice-site
recognition motifs giving rise to CEACAM1-L or CEACAM1-S
isoforms. Specifically, whereas hnRNP A1 or hnRNP L promote
CEACAM1-S isoform processing, hnRNP M fosters the genera-
tion of CEACAM1-L isoforms (Dery et al., 2011). We therefore
examined whether the preferential expression of CEACAM1-S
isoforms observed in the intestinal T cells correlated with the ap-
propriate profile of hnRNP expression as determined by qPCR.
Indeed, the expression of hnRNP A1 (Figure S1I) was higher
and the expression hnRNP M (Figure S1J) lower in T cells
from PP in comparison to that observed in spleen and MLN.
As such, the hnRNP A1:hnRNP M ratio gradually increased in
T cells isolated from spleen, MLN, and PP consistent with the
increased amounts of CEACAM1-S relative to CEACAM1-L in
the intestine-associated tissues (Figure S1K). Together, these
studies indicated that the tissue-associated microenvironment
of the intestinewas uniquely promotingCEACAM1splicingwhich
resulted in predominant CEACAM1-S expression.
CEACAM1-4S Functions as an Independent Signaling
Unit in the Induction of T Cell Activation
Although CEACAM1-L isoform expression in T cells is well
known to provide important negative regulation of TCR-CD3
complex function after ITIM phosphorylation by the src-related
kinase, p56lck, and recruitment of SHP1 resulting in dephosphor-
ylation of CD3-z and ZAP70 (Chen et al., 2008; Lee et al., 2008),
very little is known about CEACAM1-S function in general or in
T cells in particular. Results in T cells are limited to transfected
in vitro model systems and remain controversial with both stim-
ulatory and inhibitory functions assigned to CEACAM1-S splice
variants (Chen and Shively, 2004a; Chen et al., 2004b). Given
the impossibility of generating a mouse specifically lacking the
CEACAM1-S splice variant without also deleting the alternative
CEACAM1-L variant, we generated CEACAM1-4S (4S) trans-
genic (Tg) mice, overexpressing the mouse 4S isoform specifi-
cally in T cells under the human CD2 (hCD2) promoter in order
to explore the function of CEACAM1-S isoforms in T cells in vivo.
The overexpression of 4S in T cells was confirmed by flow
cytometry using the CC1 mAb. These studies confirmed that
the T cells in the 4S Tg mice uniformly expressed increased
CEACAM1 (Figure S2A) with a predominance of CEACAM1-S
isoforms (Figure S2B).
When examined by flow cytometry, 4S Tg mice exhibited
greater quantities of activated CD4+ and CD8+ T cells as shown
by lower percentages of CD62LhiCD44lo naive T cells, and a
higher percentage of CD62LloCD44hi or CD62LhiCD44hi cells
consistent with effector memory and potentially central memory
T cells (Seder and Ahmed, 2003) respectively, in spleen (Fig-
ure 2A), MLN, PP, and colon LP (Figure S2C). We also noted
that 4S Tg mice exhibited increased numbers of apoptotic
CD3+ T cells (annexin V+7-AADCD3+ cells) within the peripheral
blood, spleen, MLN, and PP (Figure 2B), which correlated
inversely with decreased quantities of CD3+ cells (Figure 2C).
In spite of this, total PP and MLN cell counts were found to be
very similar betweenWTandCEACAM1-4S Tgmice (Figure S2D)
indicating that overexpression of CEACAM1-4S was selectively
depleting T cells. Intracellular cytokine staining of the CD4+
T cells isolated from spleen, MLN, and PP also revealed thatmmunity 37, 930–946, November 16, 2012 ª2012 Elsevier Inc. 933
Figure 2. CEACAM1-4S Is Associated with Activation of Primary T Cells
(A) Spleen cells were first gated on CD3+ cells, and either CD4+ or CD8+ cells, and later examined for CD44 and CD62L expression. 4S Tg mice possessed lower
percentages of CD62LhiCD44low naive T cells and higher percentages of CD62LlowCD44hi effector memory T cells when compared to WT mice.
(B and C) Compared to WT littermates, 4S Tg mice exhibited higher percentages of CD3+ Annexin V+/7AAD apoptotic cells (B) and lower percentages of CD3+
T cells (C) in various tissues (n = 5 mice per group).
(D–H) CD3+ T cells isolated from the spleen of 4S Tg mice and their WT littermates were cultured with anti-CD3 antibody at indicated concentrations, or 1 mg/ml
anti-CD3 over the indicated time course (G). Proliferation assays were performed by [3H]-thymidine incorporation (D and G); IFN-g (E) and IL-2 (F) production was
measured by ELISA; and apoptosis was determined using annexin-V and 7-AAD staining (H) (n = 5 mice per group).
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Function of CEACAM1-S in Intestinal T CellsIL-2, IL-4, IL-10, IL-17, IFN-g, and TGF-b were all increased in
the T cells of 4S Tg mice when compared to that observed
in WT littermates (Figure S2E). As illustrated in Figure S2F for
IFN-g, CEACAM1-S induction of cytokines influenced the total
CD4 + T cell population consistent with a broad activating func-
tion of the 4S isoform when highly expressed. CD3+ T cells iso-
lated from the spleen of 4S Tg mice also exhibited a higher
proliferation rate (Figure 2D) and more IFN-g (Figure 2E) and
IL-2 (Figure 2F) secretion upon anti-CD3 stimulation ex vivo in
comparison to that associated with T cells from WT littermate
controls. However, with longer time-periods of culture, the prolif-
eration rate of splenic CD3+ T cells from the 4S Tg mice was
observed to be lower than that detected with the WT littermates
after stimulation, consistent with in vitro T cell contraction due to
increased activation-induced cell death (AICD) in the presence of
the 4S isoform (Figure 2G). Consistent with this, splenic 4S Tg
T cells exhibited increased annexin V staining (Figure 2H) and
cleavage of caspase 3 (Figure 2I) after 3 hr of anti-CD3 stimu-
lation. These results showed that themouse 4S isoformboth cos-
timulatedprimary Tcells and sensitized them toAICD, supporting
previous in vitro transfection studies, which ascribe activating
functions to this CEACAM1 isoform in contrast to the inhibitory
functions of the L isoform (Chen and Shively, 2004a; Chen
et al., 2004b). Moreover, these observations further supported
the idea that both the increased total CEACAM1 expression
and the enrichment of the activating S isoform observed on
T cells in intestinal tissues are associated with the effector
memory T cell phenotype, which predominates in the normal
intestinal LP under steady-state conditions (Hurst et al., 1999).
The Activating Function of CEACAM1-4S in T Cells Is
Observed Independently of CEACAM1-L Isoform
Expression
Because the studies we performed in 4S Tg mice were under-
taken in the context of endogenous CEACAM1 expression, it
was possible that the apparent activating and inhibiting functions
of the 4S isoform were either the consequence of CEACAM1-
mediated neutralization of CEACAM1-L inhibitory function and/
or the result of a direct activating signal by CEACAM1-S. To
examine this question, we generated 4S Tg mice that lacked
expression of any other CEACAM1 isoforms by crossing 4S
Tg mice with Ceacam1/ mice on a C57BL/6 background
(Ceacam1/-4S Tg). Although less than that observed in 4S Tg
T cells containing endogenous amounts of CEACAM1 in all cell
types, Ceacam1/-4S Tg mice still contained more activated
T cells in vivo as revealed by lower percentages of CD4+(or
CD8+) CD62LhiCD44lo naive T cells, and higher percentages of
CD4+(or CD8+) CD62LloCD44hi effector memory T cells in spleen
(Figure 2J), MLN, PP, and colon LP (Figure S2G) in comparison to
Ceacam1/ littermates.Ceacam1/-4S Tgmice also exhibited(I) CD3+ T cells were isolated from the spleen of 4S Tg or WT mice, and culture
prepared at the indicated times, and caspase-3 and its activated form were dete
(J–L) Compared to Ceacam1/ mice, Ceacam1/-4S Tg mice have lower
CD62LlowCD44hi effector memory T cells in the spleen (J), higher percentages of a
(n = 5 mice per group).
(M–O) T cells isolated from spleen ofWT,Ceacam1/,Ceacam1/-4S Tg (4S Tg
indicated concentrations and proliferation assayswere performed by [3H]-thymidi
(n = 4 mice per group). All data are mean ± SEM; *p < 0.05 (two-tailed Student’s
Imore apoptotic CD3+ T cells within the MLN, blood, and PP (Fig-
ure 2K), inversely correlating with a decrease in CD3+ cells (Fig-
ure 2L). CD4+ T cells isolated from the spleens of Ceacam1/-
4S Tg mice also proliferated more vigorously (Figure 2M) and
secreted more IL-2 (Figure 2N) and IFN-g (Figure 2O) upon anti-
CD3 stimulation. Notably, splenic CD4+ T cells fromCeacam1/
mice exhibited increased activation upon anti-CD3 stimulation
that was intermediate to the anti-CD3 induced stimulation
observed with WT and Ceacam1/-4S Tg T cells (Figures 2M–
2O). On the other hand, splenic T cells from mice in which only
the CEACAM1-4L (4L) isoform was expressed by T cells, gener-
ated by crossing previously established 4L Tg mice (Nagaishi
et al., 2006)withCeacam1/mice, exhibited a blunted response
to anti-CD3 stimulation that was less than that observed with
WT T cells and is consistent with the inhibitory functions of
this isoform (Figures 2M–2O). Taken together, these studies
showed that loss of dominant endogenous CEACAM1-L in-
hibitory function in Ceacam1/ mice or gain of CEACAM1-S
expression independently of CEACAM1-L isoforms, as observed
in Ceacam1/-4S Tg T cells, resulted in enhanced TCR-CD3
complex signaling. In comparison, gain of CEACAM1-L iso-
forms independently of CEACAM1-S isoforms led to inhibition
of T cell function. Thus CEACAM1-S and CEACAM1-L were
able to function as independent activating and inhibitory sig-
naling units in T cells. Moreover, the blunted effects of CEACAM1
overexpression on T cells in vivo in the absence of CEACAM1
expression elsewhere (Figures 2J–2L) not only highlights the
importance of homophilic interactions presumably in trans with
CEACAM1 on non-T cells but also suggests a possible role for
other heterophilic ligands in CEACAM1 activation.
CEACAM1-4S Isoform Function Is Associatedwith NFAT
Signaling
The studies described above suggested that CEACAM1-S iso-
forms possess direct signaling functions in T cells. However,
the mechanisms by which this might occur are unknown. To
clarify the possible signaling pathways involved in the functions
observed as a consequence of CEACAM1-4S expression on
primary T cells, we performed Affymetrix cDNA microarray anal-
ysis on primary CD4+ T cells isolated from MLN of WT or 4S Tg
mice and compared their transcriptional profiles. By doing so,
we identified an elevation of a number of genes associated
with the Ca2+- nuclear factor of activation (NFAT) signaling path-
way (Hermann-Kleiter and Baier, 2010) (Table S1). These in-
cluded cytokines such as IFN-g, IL-2, and IL-4 and cell surface
proteins such as CD40L.
We therefore assessed NFAT expression and its intracellular
distribution in primary CD4+ T cells from the MLN of WT, 4S
Tg,Ceacam1/, andCeacam1/-4S Tgmice. Themost impor-
tant finding was that CD4+ T cells from 4S Tg or Ceacam1/-4Sd with IL-2 (100 U/ml) or anti-CD3 (1 mg/ml) coated plates. Cell lysates were
rmined using immunoblot.
percentages of CD62LhiCD44low naive T cells and higher percentages of
nnexin V+/7AAD apoptotic cells (K) and lower percentages of CD3+ T cells (L)
/KO), orCeacam1/-4L Tg (4L Tg/KO) mice were cultured with anti-CD3 at the
ne incorporation (M). IL-2 (N) and IFN-g (O) productionweremeasured by ELISA
t test), ND = not detected.
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Figure 3. Overexpression of CEACAM1-4S
on T Cells Enhances the Nuclear Transloca-
tion of NFAT1
(A and B) Immunoblot of whole cell lysates (Total),
cytosolic (Cyto), and nuclear (Nuc) extracts of
splenic CD4+ T cells isolated from (A) WT and 4S
Tg or (B) Ceacam1/ and Ceacam1/-4S Tg (4S
Tg/KO) mice with anti-NFAT1, anti-GAPDH, or
b-actin antibodies.
(C) Frozen sections of PP from WT or 4S Tg
animals were stained with anti-CD4 (red), anti-
NFAT1 (green), and DAPI (blue). Areas of overlap
are indicated by white arrows. Data are repre-
sentative of three pairs of animals.
Immunity
Function of CEACAM1-S in Intestinal T CellsTg mice exhibited an obvious increase in the quantities of intra-
nuclear NFAT relative to the amounts observed in the T cells
from their WT or Ceacam1/ littermate controls, respectively,
as defined by immunoblotting with an NFAT1-specific antibody
in the setting of similar amounts of intranuclear b-actin (Fig-
ures 3A and 3B). These biochemical studies were confirmed by
the morphological examination of tissues from 4S Tg mice (Fig-
ure 3C), which revealed increased intranuclear accumulation of
NFAT in CD4+ T cells within the PP of 4S Tg mice in comparison
to that observed in the PP of WT littermate controls (Figure 3C).
These studies confirmed the activating function of the 4S isoform
and suggest that CEACAM1-S-mediated activation of T cells
involves NFAT.
CEACAM1-4S on T Cells Regulates Peyer’s Patches and
the Generation of IgA-Dependent Secretory Immunity
Given the relative importance observed for CEACAM1-S
isoforms in T cells within intestinal tissues, including their enrich-
ment in the S isoform and increased expression of NFAT-depen-
dent factors such as CD40L, we next sought to determine
whether the functions associated with CEACAM1-S-mediated
signaling were linked to normal physiologic operations within
the intestines. We first observed that, despite being present in
equal numbers (Figure 4A), PP of 4S Tg small intestine were
considerably larger in size than those of their WT counterparts
(Figure 4B). Using a previously published scoring system, which
takes into account both PP frequency and size (Barreau et al.,
2007), we determined that the total surface area occupied by
PP of 4S Tg small intestine was substantially greater than that as-
sociated with their WT counterparts (Figure 4C). Because similar
observations were made when Ceacam1/-4S Tg mice were
compared to Ceacam1/ littermate controls (Figure 4D), these936 Immunity 37, 930–946, November 16, 2012 ª2012 Elsevier Inc.observations provided evidence that
enlarged PP size was a direct conse-
quence of CEACAM1-S function.
We therefore next examined B cell
development in the PP of WT and 4S Tg
mice. As shown in Figure 4E (and Table
S2), we detected increased B220IgA+
cells resembling activated plasma cells
by flow cytometry in the PP and LP of 4S
Tgmice relative toWT littermate controls.
Consistent with this, the proportion of
B220IgA+ cells was decreased in the
PP of Ceacam1/ mice relative to their WT littermate controls
(Figure 4F; data not shown). Using immunofluorescence micros-
copy,we confirmed the specific localization of theseplasmacells
in the PP ofWT and 4S Tgmice (Figure 4G). In contrast, no differ-
ences were seen in the frequency of B220+IgA+ cells in either the
PP or LP ofWT and 4S Tgmice (Table S2). These studies showed
that the PP of 4S Tg exhibited an increase in activated, IgA-
committed plasma cells and that Ceacam1/ mice
demonstrated a corollary decrease in such cells, thereby con-
firming the physiological requirement for CEACAM1-S in estab-
lishing an adequate plasma cell distribution in the intestine.
We thenexamined the functional consequences ofCEACAM1-
4S in T cells on gut B cells by studying the immunoglobulin
content of the intestinal secretions from 4S Tg and Ceacam1/
mice. These studies revealed that the quantity of secreted IgA
correlated with CEACAM1-4S expression in that lumenal IgA,
but not IgG, was increased in 4S Tg mice and decreased in
Ceacam1/ mice relative to WT littermate controls (Figure 4H).
Although there were no significant differences in the serum
IgA concentration observed in WT and Ceacam1/ animals,
there was a slight trend toward an increase in serum IgA, but
not IgG concentrations, in 4S Tg mice compared to WT litter-
mate controls (Figure 4I). Together, these data revealed that
CEACAM1-S leads to increases in both the quantity and activity
of IgA+ plasma cells in intestinal tissues, enlarging the size of PP
and enhancing secretory immunity.
CEACAM1 Regulates Mucosal Defense to Oral Listeria
monocytogenes Infection
We next determined whether the physiological role of
CEACAM1 in regulatingPP-mediated secretory immunity through
CEACAM1-S expression extended to defense against a mucosal
Immunity
Function of CEACAM1-S in Intestinal T Cellspathogen. In this regard, we chose to study Listeria monocyto-
genes, a Gram-positive intracellular pathogen, because pre-
vious studies indicate that Ceacam1/ mice are susceptible
to an intraperitoneal challenge with L. monocytogenes (Pan
and Shively, 2010) and secretory immunity is likely to play an
important role in immune defense against this bacterial path-
ogen (Manohar et al., 2001). We therefore examined the
responses of Ceacam1/mice, 4S Tg mice, and their WT litter-
mates to oral infection with L. monocytogenes. Seventy-two
hr after induction of infection, the bacterial burden in both
Ceacam1/ small intestine and liver were substantially higher
than that in WT and 4S Tg mice. Specifically, a 1,000-fold
increase in colony forming units (cfu) of L. monocytogenes
was detected in the small intestine of Ceacam1/ mice and
a 100-fold increase in cfu of L. monocytogenes was observed
in the liver of Ceacam1/ mice compared to WT or 4S Tg
mice, whereas no statistically significant difference was ob-
served in the spleen for any group (Figure 4J). Conversely, the
number of L. monocytogenes recovered from the small intes-
tine, liver, and spleen of 4S Tg mice was decreased relative to
that observed in WT mice (Figure 4J). It is also notable that
the quantity of secretory IgA detected in the small intestinal
secretions of 4S Tg mice challenged with L. monocytogenes
was greatly increased relative to that observed in WT mice
(Figure 4K). Consistent with this observation, the unrestrained
L. monocytogenes infection identified in Ceacam1/ mice
was associated with decreased secretion of intestinal IgA
and increased IgA concentration in the serum of Ceacam1/
mice in response to infection (Figure 4K). These data demon-
strated that CEACAM1, and particularly CEACAM1-S, is neces-
sary for an optimal response to mucosal challenge with a bacte-
rial pathogen and that this is mediated through CEACAM1-
dependent regulation of intestinal IgA secretion.
Overexpression or Loss of CEACAM1-S on T Cells Alters
the Composition of the Commensal Microbiota
The studies above showed that a normal physiologic function
of CEACAM1 in mucosal tissues is promoting secretory immu-
nity in the PP and that this process is capable of enhancing
protection against intestinal pathogens. Because IgA is a major
regulator of the commensal microbiota (Macpherson et al.,
2001), we hypothesized that forced expression of CEACAM1-S
on T cells, as observed in 4S Tg mice, or loss of CEACAM1
expression, as observed in Ceacam1/ mice, and which lead
to increased and decreased IgA concentrations in the secre-
tions, respectively, might result in demonstrable changes in the
composition of the commensal microbiota in the ileum, the pre-
dominant site of the anatomic changes observed.
We therefore used quantitative culture methods to assess the
composition of the commensal microbiota in the ileum from
groups of age, gender, and strain matched WT, 4S Tg, and
Ceacam1/mice. Culture of full-thickness bowel and of luminal
contents is used as a means for evaluation of predominant
species found in the gut and provides a normalized assessment
of microbial biomass relative to the input mass of full thickness
segments of terminal ileum (Bjørneklett et al., 1983). Culture-
based studies are also leveraged to identify individual species
and communities of bacteria that play an essential role in elicit-
ing host phenotypes (Baumgart et al., 2007). Using aerobicIand anaerobic culture techniques and selective and differen-
tial media, as described in Supplemental Information, we
recovered nine distinct isolates from the ileum of 4S Tg and
WT mice (Table 1; Table S3). These isolates spanned three
orders, Lactobacillales, Bacillales and Bacteroidales, with 55%
of isolates belonging to the genus Lactobacillus. The microbial
diversity of the samples from 4S Tg mice was significantly
higher than that of littermate WT controls, as assessed by
multiple ecological measures of diversity (Table 1; Table S3). In
addition, certain isolates were substantially more abundant
in the 4S Tg mice as compared to WT controls, including
Gemella morbillorum, Lactobacillus murinus, and Lactobacillus
acidophilus. For Ceacam1/ mice, we recovered ten distinct
isolates spanning five orders, including those found in 4S Tg
mice, and additionally the orders Clostridiales and Bifodobacter-
iales (Table 1; Table S3). Microbial diversity of the samples from
Ceacam1/ mice was also considerably higher than that of
controls, but only one isolate, Lactobacillus brevis, was found
to be more abundant in Ceacam1/ mice (Table 1). These
studies showed that, as would be predicted by the observed
increased and decreased IgA secretion (Fagarasan, 2008;
Macpherson and Uhr, 2004) in 4S Tg and Ceacam1/ mice,
respectively, the composition of the commensal microbiota is
regulated by CEACAM1.
CEACAM1 Is Preferentially Expressed on Specific
Subsets of Circulating andTissue-Resident CD4+ TCells
Given our observations concerning the impact of CEACAM1 on
the regulation of secretory IgA and its consequences in T cell-tar-
geted 4S Tgmice as well as the known importance of T cells to B
cell development, we sought to define the subsets of CEACAM1-
regulated T cells responsible for these activities. To do so, we
focused our attention on defining the accessory molecules ex-
pressed by the small subset of CEACAM1+ T cells detected
under physiologic conditions in spleen and MLN and which
were increased in frequency in PP and LP in WT mice (see
Figure 1A). We observed that CD4+CEACAM1+ T cells from
the blood, MLN, PP, and LP expressed higher amounts of
both CD44 and CD62L than did CD4+CEACAM1 T cells (Fig-
ure 5A; Figures S3A–S3C). This is consistent with CEACAM1
being associated with effector and/or central memory T cells.
Additionally, we noted that CD4+CEACAM1+ T cells from each
of these tissue compartments expressed more a4b7-integrin
than their CD4+CEACAM1 counterparts, suggesting that
CEACAM1 expression on T cells, even those within the periph-
eral immune system, is associated with enhanced potential
to home to intestinal tissues.We also noted that CEACAM1 posi-
tivity was associated with preferential expression of PD-1, LAP
(TGFb latency associated peptide), and B220, all of which are
characteristics associated with T cell subsets possessing regu-
latory or accessory potential in the production of IgA (Fagarasan
et al., 2001; Good-Jacobson et al., 2010; Ochi et al., 2006; Oida
et al., 2003).
These observations led us to next focus on specific cell sub-
sets on which the identified molecules are known to be enriched.
In particular, because our data showed CEACAM1 expression to
be strongly cosegregating with surface LAP on CD4+ T cells from
naive WT animals (Figure 5A; Figures S3A–S3C), we carefully
examined CD4+CD25LAP+ T cells, a subset of Treg that aremmunity 37, 930–946, November 16, 2012 ª2012 Elsevier Inc. 937
Figure 4. CEACAM1 Regulates Secretory Immunity and Mucosal Defense against Oral L. monocytogenes Infection
(A) Representative methylene blue staining of the small intestine used to accurately quantify PP numbers. PPs are indicated by black arrows. One representative
picture from each group of three is shown.
(B) Hematoxylin and eosin staining shows 4S Tg mice have enlarged PP compared to that of WT mice. One representative picture from each group of eight
is shown.
(C and D) 4S Tgmice andCeacam1/-4S Tg (4S Tg/KO) mice have significantly increased numbers and size of PP when compared to that of WT orCeacam1/
mice, respectively. ***p% 0.001 (two-tailed Student’s t test) (mean, ± SEM).
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Table 1. Alterations in the Composition of the Commensal Microbiota in Mice with Overexpression of CEACAM1-4S on T Cells
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4S Tg 5.8 4.5 – – – 6.3 7.0 6.8 – 5.6 – 0 5.3 – 2.1 0.9
0 3.9 – – – 5.7 4.1 4.4 – 3.3 – 0 4.6 – 1.8 0.8
0 0 – – – 0 6.4 6.5 – 6.0 – 5.3 4.2 – 1.4 0.7
0 0 – – – 0 0 6.4 – 0 – 0 5.4 – 1.4 0.8
WT 0 0 – – – 0 0 0 – 0 – 3.0 0 – 0.0 0.0
0 0 – – – 0 3.5 3.5 – 0 – 0 0 – 0.7 0.5
0 0 – – – 0 3.0 0 – 0 – 0 0 – 0.0 0.0
0 0 – – – 0 3.6 3.0 – 0 – 0 0 – 0.7 0.5
0 0 – – – 0 0 0 – 0 – 4.6 0 – 0.0 0.0
p value 0.6 0.3 – – – 0.3 0.02 0.02 – 0.07 – 0.9 0.02 – 0.02 0.02
CC1/ – – 0 0 4.6 6.8 6.5 6.8 – 6.3 – 0 5.6 1.9 0.9
3.0 0 0 0 3.5 3.7 – 0 – 0 0 1.4 0.8
3.0 0 3.5 6.9 6.6 6.1 – 0 – 4.3 0 1.4 0.7
WT 0 6.1 0 7.0 6.9 0 – 3.0 – 0 0 1.1 0.7
0 0 0 6.2 6.0 0 – 0 – 0 0 1.1 0.7
– – 0 5.3 0 6.7 6.7 0 – 0 – 0 0 1.1 0.7
0 0 0 7.3 6.8 0 – 0 – 0 0 0.7 0.5
0 0 0 4.3 4.4 0 – 4.6 – 0 0 0.7 0.5
p value – – 0.1 0.4 0.1 0.2 0.3 0.04 – 0.6 – 0.6 0.6 0.04 0.04
Shannon and Simpson indices are measures of microbial community diversity, with larger values indicating more diverse samples. These indices take
into account the abundances of species relative to one another in a sample. Numbers in bold indicate statistically significant differences.
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Function of CEACAM1-S in Intestinal T Cellsconcentrated in intestinal tissues and provide TGF-b-dependent
regulatory function and, potentially, support for secretory IgA
immunity (Niemir et al., 1995; Ochi et al., 2006; Oida et al.,
2003). Whereas on average 43.6% ± 10.9% of CD4+CD25LAP+
T cells within MLN coexpressed CEACAM1, only 2.07% ± 0.8%
of CD4+CD25LAP cells were also CEACAM1+ under steady-
state conditions in WT mice (Figure 5B). This was in stark
contrast to the CEACAM1 expression in another regulatory
T cell subset wherein similar low quantities of CEACAM1 were
observed on CD4+Foxp3+ and CD4+Foxp3 Treg cells from
the MLN (Figure 5B). We next examined the relative expression
of the CEACAM1-L and CEACAM1-S isoforms in CD4+
CEACAM1LAP, CD4+CEACAM1+LAP, or CD4+CEACAM1+(E–G) PP and LP in 4S Tg mice exhibit increased B220IgA+ plasma blasts as ass
B220IgA+ plasma blasts (F). Immunofluorescence confirmation of enrichment o
(G). Data are representative of three animal pairs.
(H and I) IgA and IgG concentrations were measured using ELISA and compared
serum (I) (nR 12 per group). *p < 0.05 (two-tailed Student’s t test) (mean, ± SD)
(J) L. monocytogenes cfu in the small intestine, liver, and spleen of WT, Ceacam1
group). *p < 0.05 (Mann-Whitney test).
(K) IgA concentrations for intestinal washes or serum isolated from diseased mice
t test).
ILAP+ cells flow-cytometrically sorted from pooled spleen and
MLN ofWTmice using the real-time PCR assay described above
(Figures S1A and S1B). Consistent with our findings in the total
population of peripheral CD4+ T cells, the ratio of L:S isoforms
was 2.78 ± 0.07 in CD4+CEACAM1+LAP cells, indicating
a predominance of the L isoform in this group of T cells (Fig-
ure 5C). In contrast, the L:S ratio was decreased to 1.16 ± 0.27
(p < 0.05) in CD4+CEACAM1+LAP+ cells indicating an enrich-
ment of the CEACAM1-S isoform in this regulatory cell subset
(Figure 5C). No differences were observed in the L:S ratio
between CD4+CEACAM1+CD25 cells (1.52 ± 0.29) and CD4+
CEACAM1+CD25+ cells (1.52 ± 0.11) isolated from the spleen
and LN (Figure S3D). These data demonstrated the existenceessed by flow cytometry (E) while PP of Ceacam1/mice possess decreased
f B220IgA+ in the PP from WT or 4S Tg animals for B220 (green) and IgA (red)
between WT, Ceacam1/, and 4S Tg littermates in the small intestine (H) and
.
/, and 4S Tg mice 72 hr after oral infection with L. monocytogenes (nR 9 per
, as measured by ELISA. (nR 9 per group). *p < 0.05; **p < 0.01 (Mann-Whitney
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Figure 5. CEACAM1-4S Is Preferentially Expressed on Specific Subsets of Both Circulating and Intestinal CD4+ T Cells
(A) Expression of CEACAM1 is associated with the enrichment of specific cell surface molecules. Percentages on histogram gates indicate the frequency of cells
positive for the given marker in the CD4+CEACAM1 and CD4+CEACAM1+ cell populations, respectively, of MLN CD3+ T cells from WT mice.
(B) CEACAM1 expression cosegregates with LAP expression and is unrelated to Foxp3 expression in CD4+ T cells from the MLN of naive WT mice.
(C) The CEACAM1-S isoform is enriched on CD4+CC1+ T cells which express LAP. T cells were isolated from pooled spleen and LN.
(D) CXCR5 is preferentially enriched on CEACAM1-expressing CD4+ T cells in the spleen and MLN of WT mice. Data are representative of five pairs of animals.
(A)–(C) show representative data from three independent experiments with n = 5–6 mice per group.
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and LAP.
The preferential expression of PD-1 noted on CD4+
CEACAM1+ T cells further led us to investigate a subset of
T cells on which this molecule is enriched. High expression
of PD-1 is associated with T follicular helper (Tfh) cells, which
regulate the formation of long-lived plasma cells by driving
the survival and selection of B cells in mature germinal cen-
ters (Good-Jacobson et al., 2010). In addition to PD-1, Tfh
cells are identified by high expression of CXCR5 (Linterman
et al., 2011) and upon investigation, we observed that CD4+
CEACAM1+ T cells from both the spleen and MLN of WT
mice are enriched in expression of this chemokine receptor
compared to their CD4+CEACAM1 counterparts (Figure 5D).940 Immunity 37, 930–946, November 16, 2012 ª2012 Elsevier Inc.Thus, our data indicated that Tfh cells preferentially expressed
CEACAM1 under physiological conditions. A deeper investiga-
tion of the CEACAM1 isoforms expressed by PD-1+CXCR5+ Tfh
cells also revealed an enrichment of CEACAM1-S isoforms in
Tfh cells from the spleen, PP, andMLN (Figure S3E). Specifically,
in contrast to the majority of peripheral CD4+ T cells, which
predominantly express CEACAM1-L isoforms, Tfh cells ex-
pressed near equal amounts of CEACAM1-L and CEACAM1-S
(Figure S3E). Collectively, these data provided evidence that
high expression of CEACAM1, and in particular enrichment of
CEACAM1-S, was a defining feature of certain subsets of CD4+
T cells under physiological conditions that serve a regulatory or
accessory role in secretory immunity and preferentially localize
to organized lymphoid structures and/or intestinal tissues.
Immunity
Function of CEACAM1-S in Intestinal T CellsCEACAM1-S Independently Regulates the Expansion
and Function of CD4+ T Cells in Which It Is Enriched
Our observations of preferential CEACAM1 expression on CD4+
CD25LAP+ and Tfh cells from WT mice led us to question the
ability of CEACAM1 to regulate these cells and, further, to inter-
rogate the relative contribution of CEACAM1-L andCEACAM1-S
isoforms in this process. Utilizing the CEACAM1 transgenic
mice, we first examined the frequency of CD4+CD25LAP+
T cells inmucosal tissues under conditions of forced overexpres-
sion of the CEACAM1-4L or CEACAM1-4S isoforms. These data
demonstrated a significant increase in the percentage of CD4+
CD25LAP+ T cells in the MLN from 4S Tg mice relative to WT
controls (Figures 6A and 6B) and in Ceacam1/-4S Tg mice
compared to Ceacam1/ controls (Figures 6C and 6D). This
increase in CD4+CD25LAP+ cells was specifically detected
under conditions of overexpression of the CEACAM1-4S isoform
in both WT and Ceacam1/ animals (Figures 6A and 6C) and
was notably absent in CEACAM1-4L transgenic mice in which
the inhibitory CEACAM1 isoform was overexpressed (Figures
6B and 6D). Given the detected increases in cell death in both
CD4+LAP- and CD4+LAP+ populations in 4S Tg animals (Fig-
ure S4A), our finding of an expanded population of viable CD4+
LAP+ T cells under conditions of CEACAM1S overexpression
can best be explained not by decreased AICD among this pop-
ulation but rather by increased generation of the CD4+LAP+
T cells in the presence of forced CEACAM1-4S expression. In
stark contrast, our analysis did not reveal any differences in the
frequency of CD4+CD25+Foxp3+ T cells upon forced expression
of CEACAM1-4S in T cells relative to that observed in WT mice
(data not shown). In order to ascertain whether enrichment
of activating CEACAM1-S was functionally relevant to CD4+
CD25LAP+ T cells, we examined the in vitro suppressive func-
tion of CD4+LAP+ T regulatory cells obtained from the MLN of
4S Tg mice. We found that these cells possessed enhanced
regulatory activity when compared to CD4+CD25LAP+ T cells
from WT controls (Figure 6E). In contrast, no differences were
observed in the regulatory potential between 4S Tg and WT
CD4+CD25+ Treg cells obtained from the MLN in similar assays
(Figure 6E). Taken together, these studies indicated that the
relative increase of CEACAM1-4S, in the absence of any con-
tribution from the inhibitory CEACAM1-L isoforms, specifically
enhanced both the development and functional capacity of regu-
latory CD4+CD25LAP+ T cells.
It is known that CD4+CD25LAP+ T cells accumulate in intes-
tinal tissues under steady-state and inflammatory conditions and
that orally administered CD3-specific antibodies induce CD4+
CD25LAP+ regulatory T cells in MLN (Boirivant et al., 2008;
Ochi et al., 2006). We thus made use of this approach in order
to determine whether CEACAM1 is specifically involved in the
induction phase of CD4+CD25LAP+ T cell development under
conditions of physiological CEACAM1 expression. Although no
significant differences were identified in the proportions of
CD4+CD25+/LAP+ Treg cells in spleen, MLN, PP, or blood of
untreated or isotype-treated Ceacam1/ and WT mice, oral
administration of anti-CD3 antibody substantially increased the
percentage of CD4+CD25LAP+ T cells in the MLN of WT but
not Ceacam1/ mice (Figure 6F; data not shown). In contrast,
oral administration of a CD3-specific antibody was not observed
to alter the percentage of CD4+Foxp3+ T regulatory cells in theIMLN of WT or Ceacam1/ mice (Figure S4B). These studies
confirmed a physiological role played by CEACAM1 in regulating
the expansion of CD4+CD25LAP+ T cells in mucosal tissues as
well as in promoting their suppressive function.
Given our observation of PP enlargement in 4S Tg mice and
the preferential expression of CEACAM1-S in Tfh cells in WT
mice, we next examined the impact of highly abundant
CEACAM1-4S on the frequency of Tfh cells in the spleen, MLN
and PP of 4S Tg mice. Flow cytometric analysis of each of these
tissues revealed an enrichment not only of PD-1 itself (Fig-
ure S4C) but also of the PD-1+CXCR5+ population of Tfh cells
in the 4S Tg mice compared to their WT littermate controls (Fig-
ure 6G). Importantly, CEACAM1-4S-mediated enrichment of Tfh
cells occurred completely independently of the CEACAM1-4L
isoform since Ceacam1/-4S Tg mice also contained much
higher amounts of Tfh cells than their Ceacam1/ counterparts
(Figure 6H). Collectively, our data are consistent with a role for
CEACAM1-S isoforms in promoting the development of two
types of accessory cells (CD4+CD25LAP+ T cells and Tfh cells),
which are not only enriched in organized lymphoid structures
and mucosal tissues but are also known to be involved in B
cell activation (Cerutti, 2008; Good-Jacobson et al., 2010), and
likely thus contribute to the ability of CEACAM1 to regulate
secretory intestinal immunity.
DISCUSSION
Here, we provide evidence for tissue and cell-type specific
regulation of CEACAM1 splicing in T cells which results in the
unique predominance of CEACAM1-S isoforms in intestinal resi-
dent T cells and specific subsets of T cells associated with
humoral immunity. Although CEACAM1 is an activation-induced
molecule on T cells, the observed tissue-specific splicing was
not due to activation of the T cells per se because it was
not observed when T cells were stimulated ex vivo. Adoptive
transfer experiments demonstrated that CEACAM1-S domi-
nance was gained by naive peripheral T cells upon entry into
the intestines and was lost when mucosal T cells were removed
from the intestines and restimulated ex vivo. This indicated
that the specific mucosal milieu of the intestines promotes
CEACAM1-S expression in T cells. Moreover, our results in 4S
Tg mice indicated that CEACAM1-S facilitates T cell activation
and the induction of secretory IgA immunity. Consistent with
this, T cell subsets that bore a memory phenotype characteristic
of mucosal tissues (Gibbons and Spencer, 2011) and specific
subsets of T cells such as CD4+CD25LAP+ and Tfh cells, which
encourage secretory immunity, displayed an enrichment upon
CEACAM1-S expression and were driven by its presence.
Thus, CEACAM1-S expression is promoted and maintained by
the mucosal environment and facilitates T cell activation linked
to the generation of cell types responsible for mucosal regulation
and protection.
The mucosal factors responsible for this preferential splicing
within the mucosal microenvironment of the intestines are
unknown. We showed that the differential splicing of CEACAM1
occurred independently of microbial factors, as observed in GF
mice, and related signaling pathways such as MYD88 and
NOD2. This suggests that microbial-independent tissue-specific
factors and their own related pathways regulate CEACAM1mmunity 37, 930–946, November 16, 2012 ª2012 Elsevier Inc. 941
Figure 6. CEACAM1-S Directly Enhances the Generation of CD4+LAP+ and Tfh Cells
(A–D) The percentage of CD4+LAP+ cells is increased in MLN of naive 4S Tgmice (A) but not 4L Tg mice (B).Ceacam1/-4S Tg mice (C) but not Ceacam1/-4L
Tg mice (D) are enriched in CD4+LAP+ T cells compared to their littermate controls.
(E) Overexpression of CEACAM1-4S enhances the regulatory function of CD4+LAP+ Treg cells in vitro as shown by the decrease in proliferation of responder
T cells when cocultured with CD4+LAP+ Treg cells from pooled spleen and LN of 4S Tg mice.
(F) Oral feeding of anti-CD3 antibody significantly increases the percentage of CD4+LAP+ Treg cells in the MLN of WT but not CEACAM1/mice. Mice were fed
5 mg anti-CD3 (or isotype control) for each of 5 consecutive days and CD4+LAP+ T cell frequency was assessed at day 7.
(G and H) The percentage of CD4+PD1+CXCR5+ Tfh cells in the spleen, MLN, and PP is increased 4S Tg mice (G) and decreased in Ceacam1/mice (H) when
compared to their littermate controls. All data are representative of 3 independent experiments with n = 3–6 mice per group. All data are mean ± SEM, *p < 0.05;
**p < 0.01, ***p < 0.005 (two-tailed Student’s t test).
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Function of CEACAM1-S in Intestinal T Cellssplicing and expression in the intestines. Whether these factors
include soluble (e.g., cytokines) or cell surface molecules unique
to the mucosal tissues, it is clear that they regulate both the
extent of CEACAM1 expression and the splicing of its mRNA.
These studies also demonstrated that tissue- and cell-specific942 Immunity 37, 930–946, November 16, 2012 ª2012 Elsevier Inc.regulation of Ceacam1 alternative splicing occurs in vivo and is
linked to specific immune functions.
Importantly, these studies also showed that CEACAM1-S is
not a minor isoform in primary T cells as is currently thought
(Gray-Owen and Blumberg, 2006). In transgenic mice with
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Function of CEACAM1-S in Intestinal T Cellsconditional expression of CEACAM1 in T cells, we found that
CEACAM1-S provided unique costimulatory signals that pro-
moted both AICD and an effector memory phenotype, whereas
CEACAM1-L was coinhibitory for TCR-CD3 complex signal-
ing (Nagaishi et al., 2006). Moreover, we have now shown that
CEACAM1-S in T cells can elicit this stimulation as an inde-
pendent signaling unit without CEACAM1-L assistance in vivo.
Through these properties, CEACAM1-S regulates specific sub-
sets of T cells. These cell populations include CD4+LAP+
T cells and Tfh cells that are an integral component of mucosal
tissues and organized lymphoid structures, respectively, and
are known to regulate secretory immunity (Linterman et al.,
2011). In view of CEACAM1-S enrichment in these latter cell
types irrespective of their localization to peripheral or mucosal
tissues as well as with our observations that the intestinal tissues
facilitate CEACAM1-S expression, our studies also raise that
possibility that CD4+LAP+ T cells and Tfh cells may be born in
and/or modified remotely by mucosal factors.
Although little is known about CEACAM1-S signaling in T cells,
in epithelial cells it is known to associate with the cytoskeleton
(actin and tropomyosin), calmodulin, and annexin II (Edlund
et al., 1996; Kirshner et al., 2003; Schumann et al., 2001). Such
intracellular associations, interestingly, are linked to the pro-
motion of apoptosis of mammary epithelial cells during acini
morphogenesis (Kirshner et al., 2003). In addition, consistent
with previous transfection studies in Jurkat T cells, CEACAM1-S
signaling is able to activate NFAT in vivo (Chen et al., 2004b).
As shown here, this was associated with the upregulation of
NFAT-dependent soluble and cell surface molecules such as
PD-1 and CD40L. Thus, the current studies not only demonstrate
the importance of CEACAM1-S in T cells under physiological
conditions but also their role in delivering independent signals
that may oppose those provided by CEACAM1-L isoforms.
Such observations further highlight the functional similarities
between CEACAM1 and other signaling pathways that comprise
highly related activating and inhibiting modules such as CD28
and CTLA-4 (Greenwald et al., 2005).
Presumably through its NFAT-related activation functions,
CEACAM1-S-mediated T cell activation of B cells in the PP pro-
moted the generation of IgA plasma blasts, the expansion of PP
size and IgA secretion into the lumen. Given the decreased IgA
secretion observed in the absence of CEACAM1 expression
and increased IgA secretion when CEACAM1-4S was overex-
pressed on T cells, CEACAM1-S in T cells emerges as an impor-
tant factor in directly regulating B cell function and PP structure.
PP are the essential inductive sites for regulation of antigen-
specific IgA antibody responses following oral immunization,
although a PP-independent pathway for mucosal IgA responses
also likely exists (Macpherson and Slack, 2007; Cerutti, 2008;
Hashizume et al., 2008). Previous studies show that selective
TGF-b receptor type II deficiency in B cells results in loss of
IgA-expressing cells in the spleen and PP (Borsutzky et al.,
2004; Cazac and Roes, 2000). Consistent with this,
CD4+CD25+ Tregs have been identified as major helper cells
for IgA responses to microbial antigens such as flagellin,
presumably through their secretion of TGF-b (Cong et al.,
2009). Because CD4+CD25LAP+ T regulatory cells are also
TGF-b-dependent (Ochi et al., 2006; Oida et al., 2003), were
increased in the mucosal tissues of mice that overexpress CEA-ICAM1-4S, and inadequately expanded by T cell receptor-
dependent signals in the absence of CEACAM1 expression, a
plausible mechanistic explanation for the increased IgA produc-
tion and TGF-b secretion observed in 4S Tg mice is that CD4+
CD25LAP+ T cells are a responsible factor. Additionally, the in-
creased frequency of PD-1+CXCR5+ Tfh cells that we observed
in the spleen,MLN, and PP of 4S Tgmice is likely to provide addi-
tional stimulation to IgA-producing plasma blasts because
CXCR5+ Tfh cells in B cell zones of lymphoid tissues possess
significant capacity for supporting IgG and IgA production by
B cells (Fazilleau et al., 2009a). The ability of Tfh cells to regulate
antigen-specific B cell immunity in vivo is likely linked to its high
expression of PD-1, which is NFAT-dependent (Oestreich et al.,
2008) and is known to deliver signals that promote long-lived
plasma cell responses (Good-Jacobson et al., 2010). Thus, our
studies showed that CEACAM1-S regulates secretory IgA within
PP via its ability to elicit NFAT-mediated signaling that enhances
the expression of cell surface molecules such as CD40L and
PD-1, the expansion of CD4+CD25LAP+ T cells and Tfh cells,
and the secretion of TGF-b, IL-2, IL-4, and IL-10 by CD4+
T cells, all factors that promote secretory IgA immunity (Cazac
and Roes, 2000; Cerutti, 2008; Good-Jacobson et al., 2010;
Massacand et al., 2008). As a consequence, in the absence of
CEACAM1, secretory IgA is reduced.
The ability of CEACAM1 to regulate secretory IgA produc-
tion is also interesting given the well-known role of CEACAM1
as a microbial receptor (Gray-Owen and Blumberg, 2006).
Moreover, bacteria are well-known inducers of secretory IgA
production (Macpherson and Slack, 2007) and IgA in turn
regulates the composition of the commensal microbiota
(Fagarasan, 2008). For example, IgA concentrations are very
low in GF animals with normalization of these amounts within
a few weeks following intestinal bacterial colonization after
birth (Hapfelmeier et al., 2010). IgA-deficiency is also associ-
ated with a bloom in certain organisms in the intestinal lumen
(Suzuki et al., 2004). Furthermore, secretory IgA promotes
both immune exclusion and neutralization of translocated
bacteria, which preserves intestinal barrier integrity by pre-
venting bacterial-induced inflammation (Boullier et al., 2009).
In addition, IgA can promote bacterial colonization as shown
for Helicobacter sp., which bind to the gastric epithelium via
IgA but do not invade (Taylor et al., 2007). As such, IgA
can contribute to the survival of certain classes of bacteria
within the intestines. The latter is also consistent with the
ability of secreted IgA to bind to luminal bacteria (van der Waaij
et al., 1996) and in some cases inhibit their invasiveness,
as observed during Salmonella typhimurium infection (Wijburg
et al., 2006). Consistent with this, we observed that CEACAM1
gain-of-function in T cells and loss-of-function correlated
with the ability of the host to resist the pathogenicity of
L. monocytogenes infection. Ceacam1/ and 4S Tg mice also
demonstrated increased community diversity of the commen-
sal ileal microbiota, with a predominance of Lactobacillus and
Streptococcus species as compared to WT controls. This
indicated that CEACAM1-S dependent effector functions of
these T cells have the capacity to modulate the composition
of microbial communities in the small intestine, presumably
through their effects on IgA secretion. These observations not
only further support a role for CEACAM1 in the generation ofmmunity 37, 930–946, November 16, 2012 ª2012 Elsevier Inc. 943
Immunity
Function of CEACAM1-S in Intestinal T Cellssecretory immunity but show that it is physiologically important
to the regulation and control of the intestinal microbiota and
enteropathogens.
In summary, our studies have shown that in tissue resi-
dent T cells of the intestines as well as in specific subsets of
T cells, not only are CEACAM1-S isoforms expressed but
they often dominate over CEACAM1-L isoforms. In these cells,
CEACAM1-S provides unique signals that promote populations
of T cells regulating IgA production and secretion associated
with control of the commensal microbiota and resistance to en-
teropathogens. These studies demonstrate the important role
played by CEACAM1-S isoforms in immunity.
EXPERIMENTAL PROCEDURES
Animals
WT C57BL/6 (B6) mice were purchased from The Jackson Laboratory. hCD2
promoter controlled CEACAM1-4S transgenic mice were generated in the
Brigham and Women’s Hospital Transgenic Core Facility by a similar strategy
to that previously described (Nagaishi et al., 2006). Ceacam1/ mice were
previously described (Leung et al., 2006). Myd88/ mice and Nod2/ mice
were kindly provided by Dr. S. Akira (Osaka, Japan) and Dr. K.S. Kobayashi
(Dana-Farber Cancer Institute, Boston, MA), respectively. Swiss Webster
germ-free (SWGF) mice and C57BL/6 germ-free mice (B6GF) were maintained
in germ-free isolators at Taconic. All other mice were maintained under
specific pathogen-free conditions at the Harvard Center for Comparative
Medicine at Harvard Medical School. All mice were used between 8 and
12 weeks of age. All animal experimentation was performed in accordance
with the Institutional Animal Care and Use Committee (IACUC) of Harvard
Medical School, which granted permission for this study.
Flow Cytometry
For CEACAM1 expression assays, cells were incubated with the CC1 antibody
for 20 min followed by FITC-conjugated rat anti-mouse IgG1. For other cell
surface proteins, cells were stained with the indicated fluorescence-conju-
gated antibodies for 20 min, washed, and resuspended with 1% BSA/PBS
FACS staining buffer containing DAPI (Invitrogen). Cell apoptosis assays
were performed according to the Annexin V-FITC Apoptosis Detection Kit
manual (BD Bioscience). For intracellular cytokine staining, cells were stimu-
lated with ionomycin (Sigma, 2 mg/ml), PMA (Sigma, 30 ng/ml), and Golgistop
(BD Bioscience) for 4 hr followed by intracellular cytokine staining using
Cytofix/Cytoperm solution kit according to the manufacturer’s instructions
(BD Bioscience). IgA staining was performed according to the instructions
provided with the rat anti-mouse IgA antibody (C10-3). CD4+LAP+ T cells
were stained for 20min with biotinylated anti-LAP antibody (R&D Systems) fol-
lowed by APC-conjugated streptavidin (BD Biosciences) as described pre-
viously (Ochi et al., 2006). Tfh cells were stained for CXCR5 and PD-1 as
described previously (Linterman et al., 2011). All stained cells were analyzed
on an LSRII (BD Biosciences) or a MACSQuant (Miltenyi Biotech) flow cytom-
eter, and data were analyzed using Flowjo software.
Culture-Based Studies of Ileal Microbial Community Structure
Samples of terminal ileum (2 cm from the ileocecal valve) were sterilely
dissected from mice, placed in cryovials, and immediately snap frozen on
liquid nitrogen. Samples were delivered to the Harvard Digestive Disease
Center’s (HDDC) Microbiome and Gnotobiotics Core facility on dry ice and
stored at 80C until processing. Isolation of microorganisms and determina-
tion of microorganisms is described in the Supplemental Experimental Proce-
dures and Table S3.
Oral Listeria monocytogenes Infection
Gender- and age-matched groups of Ceacam1/ mice, 4S Tg mice, and WT
littermates were housed under BL2 conditions prior to infection. Approxi-
mately 5 3 108 cfu of a 14 to 16 hr culture of L. monocytogenes strain InlAm
(Wollert et al., 2007) was suspended in 0.2 ml PBS. The suspension was deliv-
ered intragastrically to mice with a 21G feeding needle attached to a 1 ml944 Immunity 37, 930–946, November 16, 2012 ª2012 Elsevier Inc.syringe. Animals were monitored daily and at 72 hr postinfection were sacri-
ficed and dissected for histological analysis, IgA production, and determina-
tion of the number of bacteria present in the small intestine, spleen, and liver.
Cfu assays (small intestine, spleen, and liver cfu/organ) were performed as
previously described (Kaser et al., 2008).
Oral Feeding of anti-CD3
Mice were fed with anti-CD3 antibody using a protocol described previously
(Ochi et al., 2006). Specifically, groups of paired mice were fed anti-CD3 or
IgG isotype control antibody at a dose of 5 mg/mouse/day for 5 days. After
one day’s rest, mice were sacrificed at day 7 and the percentage of CD4+LAP+
regulatory T cells was determined in specific lymphoid tissues.
Suppression Assays
Regulatory T cell suppression assays were performed as previously described
(Fantini et al., 2007). Briefly, 13 105 freshly isolated splenic CD4+CD25 T cells
were stained with CFSE andmixed with an equal number of either CD4+CD25+
or CD4+LAP+ T regulatory cells isolated via magnetic sorting (Miltenyi). T cell
mixtures were then activated in the presence of soluble anti-CD3 (1 mg/ml)
and 4 3 105 irradiated total splenocytes as antigen presenters. After 4 days
of culture, CFSE dilution of the responder CD4+CD25 T cells was measured
as an indication of proliferation.
Total Serum and Secretion Immunoglobulin ELISA
The sera, intestinal washes, or fecal extracts were collected for ELISA as previ-
ously described (Hapfelmeier et al., 2010).
Immunohistochemical Analysis
PP were isolated and embedded in OCT compound (Sakura Finetechnical)
and snap frozen in dry ice. Frozen sections were prepared on micro slides
using a cryostat (Leica), and stored at 70C until use. The slides were fixed
in 100% acetone for 5 min at 4C and air-dried at room temperature. Cryo-
stat sections were blocked with 10% normal goat serum for 1 hr at room
temperature (RT). For B220 and IgA staining, the slides were stained with
purified rat anti-mouse IgA antibody for 1 hr at RT, followed by incubation
with Alexa Fluor 568 conjugated goat anti-rat IgG secondary antibody
(Invitrogen) and FITC-conjugated anti-mouse B220 antibody (BD Bioscience)
for 1 hr at RT. For NFAT staining, the slides were stained with biotin conju-
gated-anti-mouse CD4 antibody and rabbit anti-NFAT1 antibodies for 2 hr
at RT, followed by incubation with rhodamine red-X-streptavidin (Jackson
ImmunoResearch) and Alexa Fluor 488 F(ab’)2 fragment of goat anti-rabbit
IgG (H+L) (Invitrogen) for 1 hr at RT. The counterstaining was performed
using DAPI (Invitrogen). The specimens were analyzed using a Nikon Eclipse
Ti microscope.
Statistics
The Mann-Whitney U-test (two-tailed) was used to assess differences in log10
cfu in quantitative culture assays. The t test (two-tailed) was used to assess
differences between means for other data analyzed. Tests with a p value
less than 0.05 were considered statistically significant. Data are presented
as mean ± SD or ± SEM, as indicated in the figure legend. Microbial diversity
was assessed using two common ecological measures of diversity, Shannon
information entropy (Shannon, 1997) and Simpson’s diversity index (Baumgart
et al., 2007). Both measures take into account the abundances of species rela-
tive to one another in a sample.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, three tables, and Supple-
mental Experimental Procedures and can be found with this article online at
http://dx.doi.org/10.1016/j.immuni.2012.07.016.
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